search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Prokinetics to alter the position of the gastric acid pocket in Gastro Esophageal Reflux Disease.


- candidate number6355
- NTR NumberNTR1970
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR28-aug-2009
- Secondary IDsMEC 09/099 METC Academisch medisch centrum
- Public TitleProkinetics to alter the position of the gastric acid pocket in Gastro Esophageal Reflux Disease.
- Scientific TitleProkinetics to alter the position of the gastric acid pocket in Gastro Esophageal Reflux Disease.
- ACRONYMN/A
- hypothesisOur hypothesis is that alteration of the position of the postprandial acid pocket leads to less acid reflux events. The gastrokinetic properties of azithromycin might enable this effect, as was shown in the study by Mertens et al. {mertens}This study might show that treatment with prokinetics is beneficial in patients with GERD.
- Healt Condition(s) or Problem(s) studiedGastroesophageal reflux Disease (GERD), Heartburn
- Inclusion criteriaGERD patients with a hiatal hernia:
1. 18-65 years;
2. Esophagitis and/or pH-metry with an acid exposure of > 4,5%;
3. Hiatal hernia as seen on endoscopy or barium swallow of > 3 cm.
GERD patients without a hiatal hernia:
1. 18-65 years;
2. Esophagitis and/or pH-metry with an acid exposure of > 4,5%;
3. No hiatal hernia or a hiatal hernia < 2 cm as seen on endoscopy or barium swallow.
- Exclusion criteria1. Surgery of the gastrointestinal tract other then appendectomy;
2. Use of medication that interfere with gastrointestinal motility;
3. Inability to stop the use of proton pump inhibitors twice for one week;
4. Participation in another study with exposure to radiation within the last year.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingDouble
- controlPlacebo
- groupCrossover
- TypeSingle arm
- Studytypeintervention
- planned startdate 9-jan-2009
- planned closingdate9-jan-2010
- Target number of participants20
- InterventionsAdministration of azitromycin.
- Primary outcomeThe rate of acid reflux episodes.
- Secondary outcome1. The rate of acid versus non acid reflux events;
2. The position of the acid pocket, relative to the lower esophageal sphincter and crural diaphragm;
3. The rate of TLESRs;
4. Gastric emptying.
- Timepoints2 test days, separated by a min of 2 weeks.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDr. G.E.E. Boeckxstaens
- CONTACT for SCIENTIFIC QUERIESDr. G.E.E. Boeckxstaens
- Sponsor/Initiator Academic Medical Center (AMC), Department of Gastroenterology
- Funding
(Source(s) of Monetary or Material Support)
Academic Medical Center (AMC), Department of Gastroenterology
- PublicationsN/A
- Brief summaryGastro-esophageal reflux is a common phenomenon in which gastric contents flow back into the esophageal lumen, which can cause symptoms and/ or esophageal damage. Most reflux episodes occur during transient relaxations of the lower esophageal sphincter (TLESR). The rate of TLESRs is however comparable in healthy subjects and patients with gastro-esophageal reflux disease (GERD). In contrast, several studies agree that the risk to have acidic reflux during a TLESR is twice as large in GERD patients compared to healthy subjects. Esophageal acid exposure is of great importance for development of symptoms and/or esophageal damage.
Recently our lab has shown that the main factor in this difference is the position of the postprandial acid pocket. The acid pocket is an unbuffered pool of acid floating on top of the meal in the proximal stomach, where it is the most important source of refluxate. By injection of 99mTc-pertechnetate we were able to visualize this pool of acid scintigraphically, as 99mTc-pertechnetate is also secreted by parietal cells in the stomach.
The most important finding of the study was that in patients with a large hiatal hernia, the acid pocket may be trapped in the hiatal sac above the diaphragm allowing acid reflux to occur during episodes of low LES pressure. This explains the increased risk to have acidic gastroesophageal reflux during a TLESR, when the LES relaxes after swallowing or when LES pressure is low in patients with a hiatal hernia.
The macrolide Azitromycin is a bacterostatic antibiotic, with gastroprokinetic properties. Erytromycin, a comparable macrolide alters proximal gastric volume and postprandial relaxtion time. Administration of Azitromycine in patients after lung transplant has shown to lower the rate of reflux episodes. Interestingly, it mainly alters the rate of acidic reflux events, suggesting that it alters the position of the acid pocket, as macrolides have no influence on acid secretion or TLESRs. Therefore, our aim is to show that the administration of Azitromycin leads to an altered position of the acid pocket scintigraphically, and it thereby changes the rate of postprandial acid reflux episodes.
- Main changes (audit trail)
- RECORD28-aug-2009 - 12-okt-2009


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl